Presented by
Management Forum
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness Training Course
Delve into the world of additional Risk Minimization Measures (aRMMs) and explore everything from the regulatory framework surrounding aRMMs to their impact on patient safety and healthcare outcomes.
9 April 2025
+ 10 September 2025, 3 December 2025 »
from £350
- Format: Live online
- CPD: 3 hours for your records
- Certificate of completion
- Signal Detection and Regulatory Expectations
- A Practical Guide to Producing and Maintaining the PSMF
- A Practical Guide to Writing Risk Management Plans (RMPs)
- AI in Pharmacovigilance
- Additional Risk Minimization Measures (aRMMs) and Their Effectiveness
- Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP)
Course overview
This course delves into the world of additional Risk Minimisation Measures (aRMMs), providing a thorough understanding of their development, implementation and assessment. Participants will explore the regulatory framework surrounding aRMMs, learn how to design effective risk minimisation strategies and evaluate their impact on patient safety and healthcare outcomes. This course combines theoretical knowledge with practical insights, enabling attendees to enhance their skills in managing and monitoring aRMMs in their organisations.
This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.
Benefits of attending
- Gain in-depth knowledge of aRMMs, including their purpose, development and regulatory requirements
- Learn how to create and implement effective risk minimisation strategies tailored to specific safety concerns
- Discover methods for assessing the effectiveness of aRMMs and making data-driven improvements
- Stay informed about the latest regulatory guidelines and best practices for aRMMs
- Explore the ethical aspects of implementing aRMMs and ensuring patient safety
Who should attend?
- Pharmacovigilance specialists
- Drug Safety Officers
- Regulatory affairs professionals
- Clinical research associates
- Medical affairs personnel
- Risk management professionals
- Healthcare Quality Assurance specialists
This course will cover:
Introduction to aRMMs
- Overview of additional Risk Minimisation Measures
- Importance and objectives of aRMMs and their effectiveness evaluation
Understanding global regulatory guidelines for aRMMs
- Key regulatory requirements and compliance
- How new safety data affect decisions and benefit-risk balance
Principles of designing risk minimization strategies
- Designing Effective aRMMs
- Case study on aRMM implementations
Practical approaches to implementing aRMMs
- Implementation Strategies: Engaging stakeholders and ensuring adherence
- Real-world scenarios and problem-solving
Methods for monitoring and assessing the impact of aRMMs
- Data collection, analysis, and reporting
- Ethics in aRMM Implementation
Alina Panourgia
Composite Pharma
Alina Panourgia is an experienced QA/PV Auditor and Regulatory Affairs professional, with a career spanning various regions.
Alina started her career in SEA working at the manufacturing site leading Quality Control/Regulatory Affairs department. She still prepares companies for inspections and provides trainings.
Since relocating to the Middle East in 2015, Alina has worked as a freelancer, collaborating with UK, US and EU companies on PV projects. Additionally, Alina has overseen regulatory submissions and pharmacovigilance activities in the MENA, LATAM and CIS regions.
Alina is a frequent speaker at international forums, conferences and training programs, sharing her expertise on various topics in pharmacovigilance, regulatory affairs and quality improvements.
She has presented at GCC Regulatory Affairs/PV Summits, Drug Safety Symposiums and other significant industry events within MENA region.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
9 April 2025
Live online
09:00-12:30 UK (London) (UTC+01)
10:00-13:30 Paris (UTC+02)
04:00-07:30 New York (UTC-04)
Course code 15386
- GBP 350 400
- EUR 490 560
- USD 562 640
Until 05 Mar
- 3 hours of live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
10 September 2025
Live online
09:00-12:30 UK (London) (UTC+01)
10:00-13:30 Paris (UTC+02)
04:00-07:30 New York (UTC-04)
Course code 15387
- GBP 350 400
- EUR 490 560
- USD 562 640
Until 06 Aug
- 3 hours of live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
3 December 2025
Live online
09:00-12:30 UK (London) (UTC+00)
10:00-13:30 Paris (UTC+01)
04:00-07:30 New York (UTC-05)
Course code 15388
- GBP 350 400
- EUR 490 560
- USD 562 640
Until 29 Oct
- 3 hours of live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Denmark
- 2care4 Generics ApS
